期刊文献+

基质金属蛋白酶3在实验性大鼠腹主动脉瘤模型中的表达 被引量:2

Expression of matrix metalloproteinase-3 in experimental abdominal aortic aneurysm rat model
暂未订购
导出
摘要 目的 :检测基质金属蛋白酶 3(MMP- 3)在大鼠正常动脉及腹动脉瘤模型组织中的表达 ,以探讨其在腹主动脉瘤发病机制中的作用。方法 :建立大鼠腹主动脉瘤灌注模型 ,应用免疫组织化学和分子原位杂交技术检测 MMP- 3的表达。结果 :正常动脉壁组织 MMP- 3蛋白表达为弱阳性或阴性 ,而动脉瘤组织中 MMP- 3蛋白表达显著增高 ,阳性率为 8/ 8;MMP- 3阳性染色主要位于中膜的平滑肌细胞和外膜的炎症细胞 ,其中炎症细胞浸润的区域染色明显增强。 MMP- 3m RNA在动脉瘤组织中呈阳性表达 ,在动脉外膜炎症细胞浸润的区域和小血管聚集区呈强阳性 ;对照组动脉组织未见 MMP- 3m RNA阳性表达。 结论 :腹主动脉瘤组织中 MMP- 3蛋白及 m RNA较正常动脉组织表达显著增高 ,尤其在炎症细胞浸润的区域表达明显增强 ;提示 MMP- Objective:To investigate matrix metalloproteinase 3 (MMP 3) expression in experimental abdominal aortic aneurysms (AAA) rat model. Methods:The expression of MMP 3 were observed in 8 rat AAA models and 8 normal control aortic tissues using immunohistochemistry and molecular in situ hybridization technique. Results:The positive rate of MMP 3 protein expression was 8/8 in AAA and it was markedly increased compared with that of control samples( P <0.01). The positive expression of MMP 3 protein, mostly in adventitia inflammatory infiltration areas and media vascular smooth muscle cells in AAA model tissues, was much stronger than that of control aortic tissues. The expression of MMP 3 mRNA in AAA group was much stronger than that in control group. The expression pattern of MMP 3 mRNA in AAA was consistent with expression of MMP 3 protein. Conclusion:The protein and mRNA expression of MMP 3 is markedly increased in experimental AAA than in control abdominal aortic tissues. MMP 3 may be a key initial factor in experimental AAA formation and progression.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2002年第8期877-879,共3页 Academic Journal of Second Military Medical University
基金 军队杰出人才基金资助项目 (98J0 0 5 ) 上海市卫生系统百名跨世纪优秀学科带头人培养计划基金(97BR0 4 7) 上海市科技发展基金攻关计划项目(0 0 4 4 190 2 9) 长海医院学科攀登计划基金资助课题
关键词 基质金属蛋白酶3 大鼠 腹主动脉瘤 免疫组织化学 原位杂交 aortic aneurysm,abdominal metalloproteinases immunohistochemistry in situ hybridization model,cardiovascular
  • 相关文献

参考文献5

  • 1[1]Shah PK.Inflammation,metalloproteinases,and increased proteolysis,an emerging pathophysiological paradigm in aortic aneurysm[J].Circulation,1997,96(7):2115-2117.
  • 2[2]Anidjar S,Salzmann JL,Gentric D,et al.Elastase induced experimentalaneurysms in rats[J].Circulation,1990,82(3):973-981.
  • 3[3]Davis V,Persidskaia R,Baca-Regen L,et al.Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms[J].Arterioscler Thromb Vasc Biol,1998,18(10):1625-1633.
  • 4[4]Freestone T,Turner RJ,Coady A,et al.Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm.Arterioscler[J].Thromb Vasc Biol,1995,15(8):1145-1151.
  • 5[5]McMillan WD,Patterson BK,Keen RR,et al.In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal,occlusive,and normal aorta[J].J Vasc Surg,1995,22(3):295-305.

同被引文献14

  • 1许端敏,李玉光,王东明,石永英,陈畅,袁文金.动脉损伤后基质金属蛋白酶-3的变化[J].岭南心血管病杂志,2003,9(2):128-129. 被引量:2
  • 2徐磊,卢兴国,陈怀红,傅海涯,林小莉,金启辉.基质金属蛋白酶3和尿激酶型纤溶酶原激活物受体在2型糖尿病大血管病变中的变化[J].中国病理生理杂志,2007,23(5):897-899. 被引量:7
  • 3Ylisirnio S,Hoyhtya M,Turpeenniemi-Hujanen T.Serum matrix metalloproteinases-2,-9 and tissue inhibitors of metalloproteinases-1,-2 in lung cancer-TIMP-1 as a prognostic marker[J].Anticancer Res,2000,20(2B):1311-1316.
  • 4Oberg A,Hoyhtya M ,Tavelin B ,et al .Limited value of preoperative serum analyses of matrix metalloproteinases(MMP-2,MMP-9) and tissue inbitors of matrix metalloproteinases (TIMP-1,TIMP-2) in colorectal cancer[J].Anticaucer Res,2000,20(2B):1085-1091.
  • 5Murphy AN,Unsworth EJ,Stetler-Stevenson WG.Tissue inhibitor of metalloproteinase-2 inhibits bFGF-induced human microvascular endothelial cell proliferation[J].J cell Physiol,1993,157 (2):351-358.
  • 6Gilles C,Polette M,Piette J ,et al .High level of MT-MMP expression is associated with invasiveness of cervical cancer cells[J].Int J Cancer,1996,65(2) :209-213.
  • 7BODH I. Jugdutt ventricular remodeling after infarction and the extracellular collagen matrix when is enough [ J ].Circulation,2003, 108 (6) : 1395 - 1403.
  • 8SAMNEGARD A, SILVEIRA A, TORNVALL P, et al. Lower serum concentration of matrix metalloproteinase-3 in the acute stage of myocardial infarction[J]. J Intern Med, 2006,259 (5) :530 - 536.
  • 9BARUTCU I, KARAKAYA O, ESEN A M, et al. Circulating stromelysin concentration is elevated inhypertensive aortic root dilatation [ J ]. Heart Vessels,2009, 24(2) : 138 - 141.
  • 10SAGLAM M, KARAKAYA O, ESEN A M, et al. Contribution of plasma matrix metalloproteinases to development of left ventricular hypertrophy and diastolic dysfunction in hypertensive subjects [ J ]. Tohoku J Exp Med,2006,208(2) : 117 - 122.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部